Skip to main content
Erschienen in: Supportive Care in Cancer 9/2014

01.09.2014 | Original Article

Psychosocial factors predicting survival after allogeneic stem cell transplant

verfasst von: Brindha Pillay, Stuart J. Lee, Lynda Katona, Sue Burney, Sharon Avery

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A primary aim was to assess the relative contribution of psychological factors, such as anxiety, depression and mental adjustment to cancer, to overall survival outcomes at a median follow-up of 2 years following allogeneic haematopoietic stem cell transplant (HSCT). A secondary aim was to ascertain if demographic, medical and psychosocial factors assessed prior to transplantation were predictors of survival for patients after accounting for post-transplant events.

Method

Between 2005 and 2011, 130 allograft patients completed the Mental Adjustment to Cancer Scale and Brief Symptom Inventory-18 as part of routine psychological assessment before undergoing transplantation. Survival status data were obtained, and predictors of survival status assessed and analysed using Cox-regression models.

Results

Thirteen percent experienced clinical levels of distress pre-transplant. None of the psychological factors predicted post-HSCT survival. In contrast, hierarchical multivariate analysis indicated that post-transplant factors (acute graft-versus-host disease and relapse post-transplant) predicted survival (Chi-square change, p < 0.001). The addition of a series of pre-transplant psychosocial and medical variables further improved the prediction of survival (Chi-square change, p = 0.01). In particular, relationship status (being single) (p = 0.04) and increased somatic symptoms (p = 0.02) pre-transplant were associated with shorter survival. Both variables were not associated with medical factors but were related to increased severity of anxiety and depressive symptoms as well as greater use of helpless-hopelessness and reduced fighting spirit adjustment response.

Conclusions

Despite the significant influence of acute post-transplant factors in predicting survival following allogeneic HSCT, multidisciplinary pre-transplant assessments are important in identifying patients who are likely to experience poorer survival outcomes.
Literatur
1.
Zurück zum Zitat Andrykowski MA, Brady MJ, Henslee-Downey PJ (1994) Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med 56:432–439PubMedCrossRef Andrykowski MA, Brady MJ, Henslee-Downey PJ (1994) Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med 56:432–439PubMedCrossRef
2.
Zurück zum Zitat Applebaum FR (1996) The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin 46:142–164CrossRef Applebaum FR (1996) The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin 46:142–164CrossRef
3.
Zurück zum Zitat Bonacchi A, Rossi A, Bellotti L, Franco S, Toccafondi A, Miccinesi G, Rosselli M (2010) Assessment of psychological distress in cancer patients: a pivotal role of clinical interview. Psychooncology 19:1294–1302PubMedCrossRef Bonacchi A, Rossi A, Bellotti L, Franco S, Toccafondi A, Miccinesi G, Rosselli M (2010) Assessment of psychological distress in cancer patients: a pivotal role of clinical interview. Psychooncology 19:1294–1302PubMedCrossRef
4.
Zurück zum Zitat Broers S, Hengeveld MW, Kaptein AA, Le Cessie S, van de Loo F, de Vries T (1998) Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. J Psychosom Res 45:341–351PubMedCrossRef Broers S, Hengeveld MW, Kaptein AA, Le Cessie S, van de Loo F, de Vries T (1998) Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. J Psychosom Res 45:341–351PubMedCrossRef
5.
Zurück zum Zitat Chang G, Orav EJ, Tong M, Antin JH (2004) Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics 45:378–385PubMedCrossRef Chang G, Orav EJ, Tong M, Antin JH (2004) Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics 45:378–385PubMedCrossRef
6.
Zurück zum Zitat Colón EA, Callies AL, Popkin MK, McGlave PB (1991) Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia. Psychosomatics 32:420–425PubMedCrossRef Colón EA, Callies AL, Popkin MK, McGlave PB (1991) Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia. Psychosomatics 32:420–425PubMedCrossRef
7.
Zurück zum Zitat Copelan EA (2006) Medical progress: haemopoietic stem cell transplantation. N Engl J Med 354:1813–1826PubMedCrossRef Copelan EA (2006) Medical progress: haemopoietic stem cell transplantation. N Engl J Med 354:1813–1826PubMedCrossRef
8.
Zurück zum Zitat Cummins R (1995) On the trail of the gold standard for subjective well-being. Soc Indicators Res 35:179–200CrossRef Cummins R (1995) On the trail of the gold standard for subjective well-being. Soc Indicators Res 35:179–200CrossRef
9.
Zurück zum Zitat Derogatis LR (2000) Brief Symptom Inventory 18: administration, scoring, and procedures manual. National Computer Systems Inc, Minneapolis Derogatis LR (2000) Brief Symptom Inventory 18: administration, scoring, and procedures manual. National Computer Systems Inc, Minneapolis
10.
Zurück zum Zitat Frick E, Motzke C, Fischer N, Busch R, Bumeder I (2005) Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? Psychooncology 14:759–770PubMedCrossRef Frick E, Motzke C, Fischer N, Busch R, Bumeder I (2005) Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? Psychooncology 14:759–770PubMedCrossRef
11.
Zurück zum Zitat Grassi L, Caruso R, Nanni MG (2013) Somatization and somatic symptom presentation in cancer: a neglected area. Int Rev Psychiatry 25:41–51PubMedCrossRef Grassi L, Caruso R, Nanni MG (2013) Somatization and somatic symptom presentation in cancer: a neglected area. Int Rev Psychiatry 25:41–51PubMedCrossRef
13.
Zurück zum Zitat Grulke N, Bailer H, Caspari-Oberegelsbacher H, Heitz V, Juchems A, Tschuschke V, Kächele H (2004) Chapter 22 Patients confronted with a life-threatening situation: the importance of defense mechanisms in patients facing bone marrow transplantation. An empirical approach. In: Wolfram E (ed) Uwe Hentschel GSJGD. Advances in Psychology, North-Holland, pp 521–534 Grulke N, Bailer H, Caspari-Oberegelsbacher H, Heitz V, Juchems A, Tschuschke V, Kächele H (2004) Chapter 22 Patients confronted with a life-threatening situation: the importance of defense mechanisms in patients facing bone marrow transplantation. An empirical approach. In: Wolfram E (ed) Uwe Hentschel GSJGD. Advances in Psychology, North-Holland, pp 521–534
14.
Zurück zum Zitat Grulke N, Bailer H, Hertenstein B, Kächele H, Arnold R, Tschuschke V, Heimpel H (2005) Coping and survival in patients with leukemia undergoing allogeneic bone marrow transplantation: long-term follow-up of a prospective study. J Psychosom Res 59:337–346PubMedCrossRef Grulke N, Bailer H, Hertenstein B, Kächele H, Arnold R, Tschuschke V, Heimpel H (2005) Coping and survival in patients with leukemia undergoing allogeneic bone marrow transplantation: long-term follow-up of a prospective study. J Psychosom Res 59:337–346PubMedCrossRef
15.
Zurück zum Zitat Grulke N, Bailer H, Larbig W, Kachele H (2006) Mental adjustment to cancer and survival of patients admitted for allogenic hemopoietic stem cell transplantation: a prospective cohort study. Psycho Soc Med 14:41–51 Grulke N, Bailer H, Larbig W, Kachele H (2006) Mental adjustment to cancer and survival of patients admitted for allogenic hemopoietic stem cell transplantation: a prospective cohort study. Psycho Soc Med 14:41–51
16.
Zurück zum Zitat Grulke N, Larbig W, Kächele H, Bailer H (2008) Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation. Psychooncology 17:480–487PubMedCrossRef Grulke N, Larbig W, Kächele H, Bailer H (2008) Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation. Psychooncology 17:480–487PubMedCrossRef
17.
Zurück zum Zitat Hoodin F, Kalbfleisch KR, Thornton J, Ratanatharathorn V (2004) Psychosocial influences on 305 adults’ survival after bone marrow transplantation: depression, smoking, and behavioral self-regulation. J Psychosom Res 57:145–154PubMedCrossRef Hoodin F, Kalbfleisch KR, Thornton J, Ratanatharathorn V (2004) Psychosocial influences on 305 adults’ survival after bone marrow transplantation: depression, smoking, and behavioral self-regulation. J Psychosom Res 57:145–154PubMedCrossRef
18.
Zurück zum Zitat Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V (2006) Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant 38:255–264PubMedCrossRef Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V (2006) Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant 38:255–264PubMedCrossRef
19.
Zurück zum Zitat Johansson M, Ryden A, Finizia C (2011) Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer: a longitudinal study. BMC Cancer 11:283–291PubMedCentralPubMedCrossRef Johansson M, Ryden A, Finizia C (2011) Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer: a longitudinal study. BMC Cancer 11:283–291PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ (2002) Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 20:2118–2126PubMedCrossRef Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ (2002) Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 20:2118–2126PubMedCrossRef
21.
Zurück zum Zitat Molassiotis A, Van den Akker OBA, Milligan DW, Goldman JM (1997) Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. J Psychosom Res 42:275–285PubMedCrossRef Molassiotis A, Van den Akker OBA, Milligan DW, Goldman JM (1997) Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. J Psychosom Res 42:275–285PubMedCrossRef
22.
Zurück zum Zitat Murphy KC, Jenkins PL, Whittaker J (1996) Psychosocial morbidity and survival in adult bone marrow transplant recipients: a follow-up study. Bone Marrow Transplant 18:199–201PubMed Murphy KC, Jenkins PL, Whittaker J (1996) Psychosocial morbidity and survival in adult bone marrow transplant recipients: a follow-up study. Bone Marrow Transplant 18:199–201PubMed
23.
Zurück zum Zitat Osborne RH, Elsworth GR, Kissane DW, Burke SA, Hopper JL (1999) The Mental Adjustment to Cancer (MAC) Scale: replication and refinement in 632 breast cancer patients. Psychol Med 29:1335–1345PubMedCrossRef Osborne RH, Elsworth GR, Kissane DW, Burke SA, Hopper JL (1999) The Mental Adjustment to Cancer (MAC) Scale: replication and refinement in 632 breast cancer patients. Psychol Med 29:1335–1345PubMedCrossRef
24.
Zurück zum Zitat Park JE, Kin KI, Yoon SS, Hahm BJ, Lee SM, Jeong HY, Shin WG, Lee HS, Oh JM (2010) Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation. Pharmacotherapy 10:1239–1246CrossRef Park JE, Kin KI, Yoon SS, Hahm BJ, Lee SM, Jeong HY, Shin WG, Lee HS, Oh JM (2010) Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation. Pharmacotherapy 10:1239–1246CrossRef
25.
Zurück zum Zitat Pillay B, Lee SJ, Katona L, Burney S, Avery S (2013) Psychosocial factors associated with quality of life in allogeneic stem cell transplant patients prior to transplant. Psychooncology. doi:10.1002/pon.3462 PubMed Pillay B, Lee SJ, Katona L, Burney S, Avery S (2013) Psychosocial factors associated with quality of life in allogeneic stem cell transplant patients prior to transplant. Psychooncology. doi:10.​1002/​pon.​3462 PubMed
26.
Zurück zum Zitat Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E, Espinal A, Gasto C (2005) Role of depression as a predictor of mortality among cancer patients after stem cell transplantation. J Clin Oncol 23:6063–6071PubMedCrossRef Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E, Espinal A, Gasto C (2005) Role of depression as a predictor of mortality among cancer patients after stem cell transplantation. J Clin Oncol 23:6063–6071PubMedCrossRef
27.
Zurück zum Zitat Rodrigue JR, Boggs SR, Weiner RS, Behen JM (1993) Mood, coping style, and personality functioning among adult bone marrow transplant candidates. Psychosomatics 34:159–165PubMedCrossRef Rodrigue JR, Boggs SR, Weiner RS, Behen JM (1993) Mood, coping style, and personality functioning among adult bone marrow transplant candidates. Psychosomatics 34:159–165PubMedCrossRef
28.
Zurück zum Zitat Rodrigue JR, Pearman TP, Moreb J (1999) Morbidity and mortality following bone marrow transplantation: predictive utility of pre-BMT affective functioning, compliance and social support stability. Int J Behav Med 6:241PubMedCrossRef Rodrigue JR, Pearman TP, Moreb J (1999) Morbidity and mortality following bone marrow transplantation: predictive utility of pre-BMT affective functioning, compliance and social support stability. Int J Behav Med 6:241PubMedCrossRef
29.
Zurück zum Zitat Sherman AC, Simonton S, Latif U, Spohn R, Tricot G (2004) Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplant 33:955–962PubMedCrossRef Sherman AC, Simonton S, Latif U, Spohn R, Tricot G (2004) Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplant 33:955–962PubMedCrossRef
30.
Zurück zum Zitat Tschuschke V, Hertenstein B, Arnold R, Bunjes D, Denzinger R, Kaechele H (2001) Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation: results of a prospective study. J Psychosom Res 50:277–285PubMedCrossRef Tschuschke V, Hertenstein B, Arnold R, Bunjes D, Denzinger R, Kaechele H (2001) Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation: results of a prospective study. J Psychosom Res 50:277–285PubMedCrossRef
31.
Zurück zum Zitat Uchino BN, Cacioppo JT, Kiecolt-Glaser JK (1996) The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull 119:488–531PubMedCrossRef Uchino BN, Cacioppo JT, Kiecolt-Glaser JK (1996) The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull 119:488–531PubMedCrossRef
32.
Zurück zum Zitat Watson M, Greer S, Bliss JM (1989) Mental Adjustment to Cancer (MAC) Scale. User’s manual. CRC Psychological Medicine Research Group, Royal Marsden Hospital, Sutton Watson M, Greer S, Bliss JM (1989) Mental Adjustment to Cancer (MAC) Scale. User’s manual. CRC Psychological Medicine Research Group, Royal Marsden Hospital, Sutton
33.
Zurück zum Zitat Watson M, Haviland JS, Greer S, Davidson J, Bliss JM (1999) Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354:331–336CrossRef Watson M, Haviland JS, Greer S, Davidson J, Bliss JM (1999) Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354:331–336CrossRef
34.
Zurück zum Zitat Watson M, Homewood J, Haviland JS, Bliss JM (2005) Influence of psychological response on survival in breast cancer: a population-based cohort study. Eur J Cancer 41:1710–1714PubMedCrossRef Watson M, Homewood J, Haviland JS, Bliss JM (2005) Influence of psychological response on survival in breast cancer: a population-based cohort study. Eur J Cancer 41:1710–1714PubMedCrossRef
Metadaten
Titel
Psychosocial factors predicting survival after allogeneic stem cell transplant
verfasst von
Brindha Pillay
Stuart J. Lee
Lynda Katona
Sue Burney
Sharon Avery
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2239-7

Weitere Artikel der Ausgabe 9/2014

Supportive Care in Cancer 9/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.